- Kidney cancer. What is the next step after failure of treatment with angiogenesis inhibitors?2010 | Second Faculty of Medicine
- Aggressive Vertebral Hemangioma2015 | Faculty of Medicine in Hradec Králové
- Regorafenib jako součást léčebného algoritmu metastazujícího kolorektálního karcinomu2015 | First Faculty of Medicine
- Immunotherapy of renal cell carcinoma2018 | First Faculty of Medicine
- Renální toxicita cílené léčby v onkologii2023 | First Faculty of Medicine
- Jak dál po ASCO 2015?2015 | First Faculty of Medicine
- Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myeloma2010 | First Faculty of Medicine
- Pharmacotherapy in ophthalmology2009 | First Faculty of Medicine
- Avastin: a case report2010 | Faculty of Medicine in Pilsen
- Nintedanib - interesting alternative forsecond line pulmonaty adenocarcinoma patients2016 | Faculty of Medicine in Pilsen
- Targeted treatment of bronchogenic carcinoma2020 | First Faculty of Medicine
- BIBF 1120 for the therapy of non-small cell lung cancer2011 | Third Faculty of Medicine
- Nintedanib in the treatment of idiopathic pulmonary fibrosis2016 | First Faculty of Medicine
- Systemic therapy of lung adenocarcinoma2016 | Faculty of Medicine in Pilsen
- Management of advanced non-small cell lung cancer +12015 | First Faculty of Medicine